Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Wit-van der Veen BJ"'
Autor:
Siebinga H; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute: Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. h.siebinga@nki.nl.; Department of Nuclear Medicine, The Netherlands Cancer Institute: Antoni Van Leeuwenhoek, Amsterdam, The Netherlands. h.siebinga@nki.nl., de Wit-van der Veen BJ; Department of Nuclear Medicine, The Netherlands Cancer Institute: Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., de Vries-Huizing DMV; Department of Nuclear Medicine, The Netherlands Cancer Institute: Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Vogel WV; Department of Nuclear Medicine, The Netherlands Cancer Institute: Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Radiation Oncology, The Netherlands Cancer Institute: Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Hendrikx JJMA; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute: Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute: Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute: Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publikováno v:
EJNMMI physics [EJNMMI Phys] 2024 Apr 24; Vol. 11 (1), pp. 39. Date of Electronic Publication: 2024 Apr 24.
Autor:
Wijngaarden JE; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. j.e.wijngaarden@amsterdamumc.nl.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands. j.e.wijngaarden@amsterdamumc.nl., Jauw YWS; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Haematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands., Zwezerijnen GJC; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands., de Wit-van der Veen BJ; Department of Nuclear Medicine, Antoni Van Leeuwenhoek Nederlands Kanker Instituut, Plesmanlaan 121, Amsterdam, The Netherlands., Vugts DJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Zijlstra JM; Department of Haematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands., van Dongen GAMS; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Boellaard R; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Menke-van der Houven van Oordt CW; Department of Medical Oncology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands., Huisman MC; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
EJNMMI research [EJNMMI Res] 2024 Feb 15; Vol. 14 (1), pp. 18. Date of Electronic Publication: 2024 Feb 15.
Autor:
Siebinga H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. h.siebinga@nki.nl.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands. h.siebinga@nki.nl., Hendrikx JJMA; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Vries-Huizing DMV; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Wit-van der Veen BJ; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Feb; Vol. 51 (3), pp. 820-827. Date of Electronic Publication: 2023 Oct 16.
Autor:
Siebinga H; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. h.siebinga@nki.nl.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands. h.siebinga@nki.nl.; Graduate School of Life Sciences, Utrecht University, Utrecht, The Netherlands. h.siebinga@nki.nl., de Wit-van der Veen BJ; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Stokkel MPM; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Dorlo TPC; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Huitema ADR; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hendrikx JJMA; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
EJNMMI physics [EJNMMI Phys] 2023 Aug 24; Vol. 10 (1), pp. 48. Date of Electronic Publication: 2023 Aug 24.
Autor:
Siebinga H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Privé BM; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Peters SMB; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Nagarajah J; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Dorlo TPC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Wit-van der Veen BJ; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hendrikx JJMA; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Aug; Vol. 12 (8), pp. 1060-1071. Date of Electronic Publication: 2023 Feb 09.
Autor:
Siebinga H; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. h.siebinga@nki.nl.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands. h.siebinga@nki.nl., Hendrikx JJMA; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Wit-van der Veen BJ; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
EJNMMI research [EJNMMI Res] 2023 Jun 15; Vol. 13 (1), pp. 60. Date of Electronic Publication: 2023 Jun 15.
Autor:
Siebinga H; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. h.siebinga@nki.nl.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands. h.siebinga@nki.nl., de Wit-van der Veen BJ; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Dorlo TPC; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Huitema ADR; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hendrikx JJMA; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
EJNMMI research [EJNMMI Res] 2023 Feb 03; Vol. 13 (1), pp. 8. Date of Electronic Publication: 2023 Feb 03.
Autor:
Siebinga H; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands; and., Heuvel JO; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., Rijkhorst EJ; Department of Medical Physics and Technology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Hendrikx JJMA; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands; and., de Wit-van der Veen BJ; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands; l.vd.veen@nki.nl.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Jan; Vol. 64 (1), pp. 63-68. Date of Electronic Publication: 2022 Jun 09.
Autor:
Siebinga H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Wit-van der Veen BJ; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Stokkel MDM; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hendrikx JJMA; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
Theranostics [Theranostics] 2022 Nov 14; Vol. 12 (18), pp. 7804-7820. Date of Electronic Publication: 2022 Nov 14 (Print Publication: 2022).
Autor:
Smit J; Department of Thoracic Oncology, NKI-AvL, Amsterdam, The Netherlands.; Department of Pulmonary Diseases, Leiden University Medical Centre, Leiden, The Netherlands., Borm FJ; Department of Thoracic Oncology, NKI-AvL, Amsterdam, The Netherlands.; Department of Pulmonary Diseases, Leiden University Medical Centre, Leiden, The Netherlands., Niemeijer AN; Department of Pulmonary Diseases, Cancer Center Amsterdam, Amsterdam University Medical Centers (VU University Medical Center), Amsterdam, The Netherlands., Huisman MC; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (VU University Medical Center), Amsterdam, The Netherlands., Hoekstra OS; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (VU University Medical Center), Amsterdam, The Netherlands., Boellaard R; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (VU University Medical Center), Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (VU University Medical Center), Amsterdam, The Netherlands., Vugts DJ; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (VU University Medical Center), Amsterdam, The Netherlands., van Dongen GAMS; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers (VU University Medical Center), Amsterdam, The Netherlands., de Wit-van der Veen BJ; Department of Nuclear Medicine, NKI-AvL, Amsterdam, The Netherlands; and., Thunnissen E; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Centers (VU University Medical Center), Amsterdam, The Netherlands., Smit EF; Department of Thoracic Oncology, NKI-AvL, Amsterdam, The Netherlands., de Langen AJ; Department of Thoracic Oncology, NKI-AvL, Amsterdam, The Netherlands; j.d.langen@nki.nl.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 May; Vol. 63 (5), pp. 686-693. Date of Electronic Publication: 2021 Aug 12.